George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Apr 2020 07:30

RNS Number : 5304J
Circassia Pharmaceuticals Plc
14 April 2020
 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc

Ian Johnson Executive Chairman

Michael Roller Chief Financial Officer

c/o FTI Consulting

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

 

Tel: +44 (0)20 7418 8900

finnCap (Joint Broker)

Geoff Nash / Alice Lane

 

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin

Tel: +44 (0) 20 3727 1000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Michael Roller

3. Jonathan Emms

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Pharmaceuticals plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. 22.85p

2. 22.683p

3. 23.2p

1. 200,000

2. 200,000

3. 300,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2020-04-09

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGLGDSCDBDGGS
Date   Source Headline
31st Dec 20157:00 amRNSTotal Voting Rights
9th Dec 201511:50 amRNSHolding(s) in Company
9th Dec 20157:00 amRNSBoard Changes
30th Nov 20157:00 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSRegulatory Approval
10th Nov 20154:20 pmRNSHolding(s) in Company
30th Oct 20157:00 amRNSTotal Voting Rights
27th Oct 20157:00 amRNSBusiness Update
30th Sep 201511:48 amRNSTotal Voting Rights
18th Sep 20156:18 pmRNSDirector/PDMR Shareholding
9th Sep 20155:55 pmRNSDirector Declaration
28th Aug 20153:34 pmRNSTotal Voting Rights
27th Aug 20155:38 pmRNSDirector Dealing
31st Jul 20159:54 amRNSTotal Voting Rights
30th Jul 20153:45 pmRNSHolding(s) in Company
28th Jul 20157:00 amRNSInterim Results
20th Jul 20153:53 pmRNSNotice of Interim Results
30th Jun 20159:28 amRNSBlock Listing Six Monthly Return
30th Jun 20159:23 amRNSTotal Voting Rights
30th Jun 20157:00 amRNSAerocrine-Increased Acceptances In Offer Period
26th Jun 20154:15 pmRNSHolding(s) in Company
15th Jun 20151:19 pmRNSCompletion of acquisition of Prosonix Limited
15th Jun 20157:00 amRNSAerocrine - extension of offer period
12th Jun 20155:33 pmRNSTR1 Notification of Major Interest in Shares
12th Jun 20153:22 pmRNSNotification Of Major Interest In Shares
11th Jun 20153:00 pmRNSNotification Of Major Interest In Shares
11th Jun 20158:09 amRNSTotal Voting Rights
10th Jun 201511:56 amRNSResult of General Meeting
9th Jun 20157:00 amRNSResults of the placing and open offer
29th May 201511:16 amRNSTotal Voting Rights Update
29th May 201511:11 amRNSDirector Dealing - Correction
20th May 20155:43 pmRNSResult of AGM
18th May 20153:14 pmRNSPublication of Circular and Prospectus
15th May 20156:40 pmRNSDetails of the placing and open offer
15th May 20153:16 pmRNSDetails of the Placing and Open Offer
15th May 20157:04 amRNSIssue of Equity
15th May 20157:00 amRNSAcquisition
8th May 201510:07 amRNSDirector/PDMR Shareholding
6th May 20156:09 pmRNSHolding(s) in Company
1st May 20151:36 pmRNSHolding(s) in Company
30th Apr 20157:00 amRNSTotal Voting Rights
31st Mar 20157:00 amRNSTotal Voting Rights
27th Mar 20154:30 pmRNSAnnual Financial Report
5th Mar 20152:58 pmRNSHolding(s) in Company
5th Mar 20152:53 pmRNSHolding(s) in Company
27th Feb 20157:00 amRNSTotal Voting Rights
26th Feb 20157:01 amRNSFinal Results
9th Feb 201510:00 amRNSAppointment of Lota S Zoth
30th Jan 20151:02 pmRNSTotal Voting Rights
27th Jan 20154:46 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.